Psychiatry and Neurology, Neurology · Fairfax, VA
NPI
1245209766
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3020 Hamaker Ct, Suite 400
Fairfax, VA, 22031
Phone (703) 876-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
1,898 services
Medicare patients, 2024
696
Average age 76
Drug cost, 2024
$1.2M
2,365 prescriptions
Company payments, 2024
$192
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marco D Castro was code 99214 (office e&m - established), 407 times for 295 patients. In total Marco D Castro billed 1,898 services in 37 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 407 | 295 | $98.21 | $40K |
| 93040 Electrocardiogram | Office | 312 | 249 | $11.41 | $3,560 |
| 99213 Office E&M - Established | Office | 174 | 154 | $73.69 | $13K |
| 95819 Neurologic | Office | 167 | 166 | $414.70 | $69K |
| 99205 Office E&M - New | Office | 160 | 160 | $186.65 | $30K |
| 99215 Office E&M - Established | Office | 100 | 94 | $151.06 | $15K |
| 99204 Office E&M - New | Office | 92 | 92 | $139.09 | $13K |
| 95816 Neurologic | Office | 76 | 76 | $357.22 | $27K |
| 95708 Neurologic | Office | 69 | 54 | $118.52 | $8,178 |
| 95886 Electrical Nerve Conductivity | Office | 63 | 32 | $86.08 | $5,423 |
| 95700 Neurologic | Office | 54 | 54 | $195.71 | $11K |
| 96116 Behavioral Health Services | Office | 45 | 45 | $72.70 | $3,272 |
| 95719 Neurologic | Office | 42 | 42 | $132.03 | $5,545 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 32 | $13.22 | $423 |
| 99212 Office E&M - Established | Office | 24 | 24 | $41.56 | $997 |
By year: 2022 $241K for 2,233 services; 2023 $242K for 1,813 services; 2024 $255K for 1,898 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marco D Castro prescribed most often to Medicare patients was Levetiracetam, with 289 prescriptions and refills. In total Marco D Castro wrote 2,365 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 289 | 599 | 64 | $11K |
| Lamotrigine Generic | 226 | 413 | 41 | $4,519 |
| Donepezil Hcl Generic | 214 | 419 | 58 | $1,540 |
| Lacosamide Generic | 171 | 284 | 29 | $24K |
| Memantine Hcl Generic | 131 | 220 | 34 | $2,939 |
| Gabapentin Generic | 123 | 217 | 37 | $1,352 |
| Divalproex Sodium Generic | 67 | 88 | Under 11 | $3,244 |
| Aptiom Eslicarbazepine Acetate | 57 | 65 | Under 11 | $136K |
| Memantine Hcl Er Memantine Hcl | 55 | 82 | 15 | $4,430 |
| Carbamazepine Er Carbamazepine | 52 | 77 | Under 11 | $12K |
| Levetiracetam Er Levetiracetam | 50 | 86 | Under 11 | $5,116 |
| Lamictal Lamotrigine | 48 | 58 | Under 11 | $50K |
| Briviact Brivaracetam | 46 | 46 | Under 11 | $65K |
| Clobazam Generic | 44 | 48 | Under 11 | $2,818 |
| Lorazepam Generic | 36 | 36 | Under 11 | $350 |
Brand drugs: 393 claims; generic drugs: 1,957 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Marco D Castro $192 ($192 in general payments such as food, travel and fees) from 2 companies. The largest payer was Lilly USA, LLC with $169.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.